MEMORANDUM OF UNDERSTANDING (MOU) SIGNING CEREMONY BETWEEN BEPHARCO AND HYUNDAI BIOSCIENCE WITHIN THE FRAMEWORK OF THE 2026 VIETNAM - KOREA ECONOMIC FORUM
On April 23, 2026, at the Hanoi branch office, Mr. Pham Thu Trieu, General Director of Bepharco, held a high-level meeting with Mr. Byoung Jun Bae, Chairman of Hyundai Bioscience. During the meeting, the leaders of both entities engaged in in-depth discussions regarding their vision and strategic cooperation orientation, officially signed a Memorandum of Understanding (MOU), and jointly attended the 2026 Vietnam - Korea Economic Forum.
The 2026 Vietnam - Korea Economic Forum was a key event organized on the occasion of the State visit to Vietnam by South Korean President Lee Jae Myung (taking place from April 21 to April 24, 2026). The event was co-chaired by the Vietnamese Ministry of Finance and the South Korean Ministry of Trade, Industry and Energy. The Forum was honored to receive the direct attention and guidance of Vietnamese Prime Minister Le Minh Hung and South Korean President Lee Jae Myung, gathering the participation of over 500 high-ranking delegates from both nations.
Notably, within the solemn framework of the Forum, under the witness of Vietnamese Minister of Finance Ngo Van Tuan and South Korean Minister of Trade, Industry and Energy Kim Jung Kwan, the Exchange Ceremony of Cooperation Documents between representative enterprises of the two countries took place successfully. Bepharco was deeply honored to be one of the representatives participating in this event, marking a significant milestone through the exchange of the MOU document with Hyundai Bioscience. This strategic cooperation agreement focuses on the research, development, and commercialization of advanced antiviral and cancer treatment drugs in the Vietnamese market.








This historic signing event is a crucial milestone that not only affirms Bepharco's position and prestige on its journey of expanding international cooperation but also serves as clear evidence of its unwavering commitment to providing advanced, high-quality medical solutions. Coupled with the extensive experience and outstanding research technology platform of Hyundai Bioscience, Bepharco strongly believes that this strategic partnership will pave the way for breakthrough advancements. Consequently, it will contribute to enhancing domestic medical treatment capacity and quality, bringing practical and sustainable health values to the Vietnamese community.